MRNA - Moderna Stock Is Moving Higher: What's Going On? | Benzinga
Moderna Inc (NASDAQ: MRNA) shares are trading higher Tuesday following positive analyst coverage from Oppenheimer.
What Happened: Oppenheimer analyst Hartaj Singh upgraded Moderna from Perform to Outperform on Tuesday and announced a price target of $142.
The news comes as the company released a letter to shareholders with timelines for its vaccine candidates and a forecast for profitability.
In the shareholder letter, Moderna CEO Stéphane Bancel said the company aims to launch up to 15 new products over the next ...